Literature DB >> 19631602

iPS cells can support full-term development of tetraploid blastocyst-complemented embryos.

Lan Kang1, Jianle Wang, Yu Zhang, Zhaohui Kou, Shaorong Gao.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19631602     DOI: 10.1016/j.stem.2009.07.001

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


× No keyword cloud information.
  165 in total

Review 1.  Induced pluripotent stem cells--opportunities for disease modelling and drug discovery.

Authors:  Marica Grskovic; Ashkan Javaherian; Berta Strulovici; George Q Daley
Journal:  Nat Rev Drug Discov       Date:  2011-11-11       Impact factor: 84.694

2.  Induced Pluripotent Stem Cells-A New Foundation in Medicine.

Authors:  George T-J Huang
Journal:  J Exp Clin Med       Date:  2010-10-22

3.  Induced pluripotent stem cell-derived hepatocytes have the functional and proliferative capabilities needed for liver regeneration in mice.

Authors:  Silvia Espejel; Garrett R Roll; K John McLaughlin; Andrew Y Lee; Jenny Y Zhang; Diana J Laird; Keisuke Okita; Shinya Yamanaka; Holger Willenbring
Journal:  J Clin Invest       Date:  2010-08-25       Impact factor: 14.808

4.  Production of mice using iPS cells and tetraploid complementation.

Authors:  Xiao-Yang Zhao; Zhuo Lv; Wei Li; Fanyi Zeng; Qi Zhou
Journal:  Nat Protoc       Date:  2010-04-29       Impact factor: 13.491

5.  Induced pluripotent stem cells: paths to new medicines. A catalyst for disease modelling, drug discovery and regenerative therapy.

Authors:  Wenbin Deng
Journal:  EMBO Rep       Date:  2010-02-19       Impact factor: 8.807

Review 6.  Embryonic and induced pluripotent stem cells as a model for liver disease.

Authors:  Hiroshi Yagi; Edgar Tafaleng; Masaki Nagaya; Marc C Hansel; Stephen C Strom; Ira J Fox; Alejandro Soto-Gutierrez
Journal:  Crit Rev Biomed Eng       Date:  2009

7.  Viable mice produced from three-factor induced pluripotent stem (iPS) cells through tetraploid complementation.

Authors:  Lan Kang; Tong Wu; Yu Tao; Ye Yuan; Jing He; Yu Zhang; Tong Luo; Zhaohui Kou; Shaorong Gao
Journal:  Cell Res       Date:  2010-11-30       Impact factor: 25.617

Review 8.  Induced pluripotent stem cells: emerging techniques for nuclear reprogramming.

Authors:  Ji Woong Han; Young-Sup Yoon
Journal:  Antioxid Redox Signal       Date:  2011-05-05       Impact factor: 8.401

9.  Complete reprogramming to all-iPS mice.

Authors:  Steven Y Cheng
Journal:  Protein Cell       Date:  2010-01       Impact factor: 14.870

10.  Critical regulation of miR-200/ZEB2 pathway in Oct4/Sox2-induced mesenchymal-to-epithelial transition and induced pluripotent stem cell generation.

Authors:  Guiying Wang; Xudong Guo; Wujun Hong; Qidong Liu; Tingyi Wei; Chenqi Lu; Longfei Gao; Dan Ye; Yi Zhou; Jie Chen; Jianmin Wang; Minjuan Wu; Houqi Liu; Jiuhong Kang
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.